Authors:
Arase, Y
Chayama, K
Ikeda, K
Tsubota, A
Suzuki, Y
Saitoh, S
Kobayashi, M
Suzuki, F
Akuta, N
Someya, T
Kobayashi, M
Kumada, H
Citation: Y. Arase et al., Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C, HEPATOL RES, 21(1), 2001, pp. 55-66
Authors:
Arase, Y
Ikeda, K
Chayama, K
Murashima, N
Tsubota, A
Suzuki, Y
Saitoh, S
Kobayashi, M
Kobayashi, M
Suzuki, F
Kumada, H
Citation: Y. Arase et al., Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration, HEPATOL RES, 19(1), 2001, pp. 22-30
Authors:
Iino, S
Tango, T
Matsushima, T
Toda, G
Miyake, K
Hino, K
Kumada, H
Yasuda, K
Kuroki, T
Hirayama, C
Suzuki, H
Citation: S. Iino et al., Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis, HEPATOL RES, 19(1), 2001, pp. 31-40
Authors:
Morikawa, H
Imamura, F
Tsurukami, Y
Itoh, T
Kumada, H
Karasawa, S
Koga, N
Iwamura, H
Citation: H. Morikawa et al., 2,2 '-Bipyridines carrying a diazo moiety and their complexes with bis(hexafluoroacetylacetonato)copper: synthesis, structures, electronic and magnetic properties of their photoproducts in frozen solutions, J MAT CHEM, 11(2), 2001, pp. 493-502
Authors:
Murashima, N
Ikeda, K
Kobayashi, M
Saitoh, S
Chayama, K
Tsubota, A
Suzuki, Y
Suzuki, F
Arase, Y
Kumada, H
Citation: N. Murashima et al., Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis, J GASTRO, 36(6), 2001, pp. 368-374
Authors:
Suzuki, F
Chayama, K
Tsubota, A
Akuta, N
Someya, T
Kobayashi, M
Suzuki, Y
Saitoh, S
Arase, Y
Ikeda, K
Kumada, H
Citation: F. Suzuki et al., Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen, J GASTRO, 36(4), 2001, pp. 242-247
Authors:
Someya, T
Suzuki, Y
Arase, Y
Kobayashi, M
Suzuki, F
Tsubota, A
Saitoh, S
Chayama, K
Murashima, N
Ikeda, K
Kumada, H
Citation: T. Someya et al., Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant, J GASTRO, 36(2), 2001, pp. 133-136
Authors:
Chayama, K
Suzuki, F
Tsubota, A
Akuta, N
Someya, T
Kobayashi, M
Arase, Y
Saitoh, S
Suzuki, Y
Ikeda, K
Kumada, H
Citation: K. Chayama et al., Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, J VIROL MET, 95(1-2), 2001, pp. 33-45
Authors:
Izumi, N
Kumada, H
Hashimoto, N
Harada, H
Imawari, M
Zeniya, M
Toda, G
Citation: N. Izumi et al., Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection - A multicenter randomized study, DIG DIS SCI, 46(3), 2001, pp. 516-523
Authors:
Tsubota, AK
Arase, Y
Ren, FR
Tanaka, H
Ikeda, K
Kumada, H
Citation: Ak. Tsubota et al., Genotype may correlate with liver carcinogenesis and tumor characteristicsin cirrhotic patients infected with hepatitis B virus subtype adw, J MED VIROL, 65(2), 2001, pp. 257-265
Authors:
Akuta, N
Chayama, K
Suzuki, F
Someya, T
Kobayashi, M
Tsubota, A
Suzuki, Y
Saitoh, S
Arase, Y
Ikeda, K
Kumada, H
Citation: N. Akuta et al., Risk factors of hepatitis C virus-related liver cirrhosis in young adults:Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)0201 allele, J MED VIROL, 64(2), 2001, pp. 109-116
Authors:
Arai, M
Minatoguchi, S
Kumada, H
Uno, Y
Nishida, Y
Hashimoto, K
Wang, NY
Takemura, G
Fujiwara, T
Higashioka, M
Kuwano, K
Fujiwara, H
Citation: M. Arai et al., Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor, BR J PHARM, 133(5), 2001, pp. 635-642
Authors:
Matsumura, A
Yamamoto, T
Shibata, Y
Nose, T
Yamamoto, K
Kumada, H
Torii, Y
Citation: A. Matsumura et al., Treatment of malignant brain tumors using nuclear reactor; Neutron capturetherapy, J ATOM E S, 43(10), 2001, pp. 957-963
Authors:
Tsubota, A
Arase, Y
Saitoh, S
Kobayashi, M
Suzuki, Y
Suzuki, F
Chayama, K
Murashima, N
Ikeda, K
Kobayashi, M
Kumada, H
Citation: A. Tsubota et al., Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study, AM J GASTRO, 96(2), 2001, pp. 557-562
Citation: S. Karasawa et al., Magnetic behavior of a 3 : 2 mixture of bis(hexafluoroacetylacetonato)copper(II) and 1,3,5-benzenetriyltris(4-pyridyldiazomethane) in a frozen solution after irradiation: Photochemical formation of a solid solution magnet, J AM CHEM S, 123(39), 2001, pp. 9685-9686
Authors:
Ikeda, K
Saitoh, S
Kobayashi, M
Suzuki, Y
Tsubota, A
Suzuki, F
Arase, Y
Murashima, N
Chayama, K
Kumada, H
Citation: K. Ikeda et al., Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data, HEPATOL RES, 18(3), 2000, pp. 252-266
Authors:
Hosoda, S
Takimura, H
Shibayama, M
Kanamura, H
Ikeda, K
Kumada, H
Citation: S. Hosoda et al., Psychiatric symptoms related to interferon therapy for chronic hepatitis C: Clinical features and prognosis, PSY CLIN N, 54(5), 2000, pp. 565-572
Authors:
Arase, Y
Ikeda, K
Chayama, K
Murashima, N
Tsubota, A
Suzuki, Y
Saitoh, S
Kobayashi, M
Kobayashi, M
Suzuki, F
Kumada, H
Citation: Y. Arase et al., Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course, J GASTRO, 35(8), 2000, pp. 607-612
Authors:
Ikeda, K
Saitoh, S
Kobayashi, M
Suzuki, Y
Suzuki, F
Tsubota, A
Arase, Y
Chayama, K
Murashima, N
Kumada, H
Citation: K. Ikeda et al., Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, J GASTRO, 35(5), 2000, pp. 353-360
Authors:
Kobayashi, M
Chayama, K
Arase, Y
Tsubota, A
Saitoh, S
Suzuki, Y
Kobayashi, M
Murashima, N
Ikeda, K
Hagiwara, M
Hashimoto, R
Nakagawa, M
Matsuda, M
Kumada, H
Citation: M. Kobayashi et al., Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance, J GASTRO, 35(10), 2000, pp. 753-757
Authors:
Kariwa, H
Yoshimatsu, K
Araki, K
Chayama, K
Kumada, H
Ogino, M
Ebihara, H
Murphy, ME
Mizutani, T
Takashima, I
Arikawa, J
Citation: H. Kariwa et al., Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in Japan, MICROB IMMU, 44(5), 2000, pp. 357-362
Citation: H. Kumada et al., Through-bond magnetic interaction between the 2p spin of the aminoxyl radical and the 3d spin of the metal ions in the complexes of bis(hexafluoroacetylacetonato)-manganese(II) and -copper(II) with 4-(N-tert-butyl-N-oxylamino)-2,2 '-bipyridine, J CHEM S DA, (6), 2000, pp. 911-914